Li Kuo Kong

Dr Li Kuo Kong’s career has spanned multiple disciplines. After attending the prestigious North Carolina School of Science and Mathematics, he investigated the role of antigen presentation on the performance of cytotoxic T cells with the immunologist, Dr Michael Edidin, at Johns Hopkins University. During residency, he was involved in clinical research at Duke University with Staphylococcal endocarditis and the utility of trans-esophageal cardiac echos. After his fellowship training at Stanford University, Dr Kong returned to the basic science lab to work on hepatitis C viral protein regulation with Dr Peter Sarnow. Dr Kong joined Diablo Infectious Diseases in 2004. Today, he enjoys working with a broad patient population in General Infectious Diseases and has a particular interest in safe medication processes within the hospital.